China SXT Pharmaceuticals-ASXTC
13F holders, Q1 2026 (March 31)4holders
$1.68avg. 13F price*
At the end of Q1 2026, 4 institutions reported holding China SXT Pharmaceuticals-A (SXTC) in their 13F filings. The largest holders were Sabby Management, LLC ($131K), UBS Group AG ($2) and Caitong International Asset Management Co., Ltd ($2).
- Company
- China SXT Pharmaceuticals-A
- CUSIP
- G2161P165
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $131K |
| Exits | 0 | $0 |
Ownership 4 holders
| Sabby Management, LLC | 2.48% | New | 78,170 | $131K |
| UBS Group AG | 0.00% | New | 1 | $2 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1 | $2 |
| Royal Bank of Canada | 0.00% | New | 13 | $0 |
"% of holder's portfolio" is SXTC's weight in each manager's 13F, not the share of China SXT Pharmaceuticals-A the manager owns.